Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhik Mukherjee

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
British Journal of Cancer|August 23, 2017
Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancerMohammed A Aleskandarany, Sultan Sonbul, Rachel Surridge, et al.
Frontiers in Oncology|December 25, 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinomaKyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Histopathology|August 4, 2017
HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissuesTalha Qaiser, Abhik Mukherjee, Chaitanya Reddy Pb, et al.
Molecular Oncology|June 2, 2014
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M A Abdel-Fatah, Roslin Russell, Nada Albarakati, et al.
Nature Communications|May 11, 2016
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
British Journal of Cancer|August 23, 2017
Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancerMohammed A Aleskandarany, Sultan Sonbul, Rachel Surridge, et al.
Frontiers in Oncology|December 25, 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinomaKyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Histopathology|August 4, 2017
HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissuesTalha Qaiser, Abhik Mukherjee, Chaitanya Reddy Pb, et al.
Molecular Oncology|June 2, 2014
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M A Abdel-Fatah, Roslin Russell, Nada Albarakati, et al.
Nature Communications|May 11, 2016
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Pageof 4